Starton Therapeutics (Starton Therapeutics) Interest Expense : $0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2050. Start your Free Trial

What is Starton Therapeutics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Starton Therapeutics's interest expense for the three months ended in Jun. 2023 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Starton Therapeutics's Operating Income for the three months ended in Jun. 2023 was $ -3.05 Mil. Starton Therapeutics's Interest Expense for the three months ended in Jun. 2023 was $ 0.00 Mil. GuruFocus does not calculate Starton Therapeutics's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Starton Therapeutics Interest Expense Historical Data

The historical data trend for Starton Therapeutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starton Therapeutics Interest Expense Chart

Starton Therapeutics Annual Data

Trend

Mar21

Mar22

Mar23

Interest Expense

Starton Therapeutics Quarterly Data
	Mar21	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23
Interest Expense	Get a 7-Day Free Trial			-	-	-	-	-

Starton Therapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Starton Therapeutics (NAS:STA) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Starton Therapeutics's Interest Expense for the three months ended in Jun. 2023 was $0.00 Mil. Its Operating Income for the three months ended in Jun. 2023 was $-3.05 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2023 was $1.42 Mil.

Starton Therapeutics's Interest Coverage for the quarter that ended in Jun. 2023 is calculated as

GuruFocus does not calculate Starton Therapeutics's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

Starton Therapeutics (Starton Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starton Therapeutics Inc (NAS:STA) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

215 College Road, Suite No.300, Paramus, NJ, USA, 07652

Website

https://www.startontx.com

Starton Therapeutics Inc is a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technology, so people with cancer can receive continuous treatment to live better, and longer. Starton's proprietary continuous delivery technology can increase the efficacy of approved drugs, make them more tolerable, and expand their potential use.

Starton Therapeutics (Starton Therapeutics) Headlines

No Headlines